Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies
- PMID: 2324685
- PMCID: PMC2187849
- DOI: 10.1084/jem.171.4.1043
Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies
Abstract
Infection of monocyte/macrophages (M/M) by a variety of viruses (including HIV-1) has been shown to be enhanced in the presence of low concentrations of antiviral antibodies. This process has been hypothesized as occurring through binding of the virus-antibody complex to Fc or complement receptors followed by endocytosis. In the current study, we explored whether such a mechanism might provide a CD4-independent route of infection by HIV-1 for any of several populations of M/M. In the absence of anti-HIV antibodies, replication of HIV-1 in M/M was blocked by viral binding inhibitors such as soluble CD4 or OKT4A mAb. Furthermore, while infection of the M/M populations by a low multiplicity of infection of HIV-1 was found to be somewhat enhanced by the presence of very low concentrations of anti-HIV antibodies, this process was also consistently inhibited by recombinant soluble CD4 and by OKT4A antibody. These results suggest that under the variety of conditions studied, CD4 binding was an essential step in the infection of M/M by HIV. Moreover, they are consistent with the notion that "enhancing" antibodies may serve to concentrate HIV onto CD4 receptors or, alternately, may act at other steps in the process of viral entry and replication.
Similar articles
-
Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro.Scand J Immunol. 1989 Oct;30(4):425-34. doi: 10.1111/j.1365-3083.1989.tb02446.x. Scand J Immunol. 1989. PMID: 2554488
-
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.J Virol. 1998 Aug;72(8):6332-8. doi: 10.1128/JVI.72.8.6332-6338.1998. J Virol. 1998. PMID: 9658072 Free PMC article.
-
Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120.J Clin Invest. 1994 Feb;93(2):885-91. doi: 10.1172/JCI117044. J Clin Invest. 1994. PMID: 8113420 Free PMC article.
-
Antibody-based inhibitors of HIV infection.Expert Opin Biol Ther. 2006 May;6(5):523-31. doi: 10.1517/14712598.6.5.523. Expert Opin Biol Ther. 2006. PMID: 16610981 Review.
-
Antiviral effects of CD4 derivatives.Curr Opin Immunol. 1989-1990 Feb;2(3):433-8. doi: 10.1016/0952-7915(89)90156-8. Curr Opin Immunol. 1989. PMID: 2576772 Review. No abstract available.
Cited by
-
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.J Virol. 1991 Aug;65(8):4309-16. doi: 10.1128/JVI.65.8.4309-4316.1991. J Virol. 1991. PMID: 1712861 Free PMC article.
-
ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection.iScience. 2022 Jan 21;25(1):103720. doi: 10.1016/j.isci.2021.103720. Epub 2021 Dec 31. iScience. 2022. PMID: 35005526 Free PMC article.
-
Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination.Blood. 2012 Oct 4;120(14):2836-42. doi: 10.1182/blood-2012-05-431361. Epub 2012 Aug 22. Blood. 2012. PMID: 22915639 Free PMC article. Clinical Trial.
-
Anti-AIDS drug development: challenges and strategies.Pharm Res. 1992 Jun;9(6):703-14. doi: 10.1023/a:1015882901078. Pharm Res. 1992. PMID: 1384026 Review.
-
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.Springer Semin Immunopathol. 1997;18(3):371-90. doi: 10.1007/BF00813504. Springer Semin Immunopathol. 1997. PMID: 9089955 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials